Parabolic Drugs Ltd. - Research Center
PARABDRUGS Group (Z) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 20 | Sep ' 18 | Sep ' 17 | Sep ' 16 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sales | - | 17.82 | 39.99 | 27.56 | 34.11 |
| Operating profit | -2.15 | -10.80 | -8.40 | -31.91 | -213.78 |
| Interest | 0.63 | 3.95 | 4.36 | 60.21 | 55.37 |
| Gross profit | -2.51 | -13.96 | -8.64 | -92.12 | -269.15 |
| EPS (Rs) | -2.05 | -4.02 | -4.34 | -19.46 | -49.52 |
Half yearly
results in details
| Sep ' 20 | Sep ' 18 | Sep ' 17 | Sep ' 16 | Mar ' 16 | |
|---|---|---|---|---|---|
| Other income | 0.27 | 0.79 | 4.12 | - | - |
| Stock adjustment | - | 4.67 | -0.91 | 25.17 | 184.00 |
| Raw material | - | 14.88 | 35.55 | 22.14 | 28.04 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.84 | 2.86 | 4.83 | 3.70 | 5.03 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.31 | 6.21 | 8.92 | 8.46 | 30.82 |
| Provisions made | - | - | - | - | - |
| Depreciation | 10.19 | 11.40 | 17.30 | 26.77 | 32.90 |
| Taxation | - | -0.48 | 0.90 | 1.54 | 4.43 |
| Net profit / loss | -12.70 | -24.88 | -26.84 | -120.43 | -306.48 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 61.89 | 61.89 | 61.89 | 61.89 | 61.89 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | 379.75 | 379.75 |
| Agg.of non promotoholding (%) | - | - | - | 61.36 | 61.36 |
| OPM (%) | - | -60.61 | -21.01 | -115.78 | -626.74 |
| GPM (%) | - | -75.01 | -19.59 | - | - |
| NPM (%) | - | -133.69 | -60.85 | - | - |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis